Literature DB >> 21839264

Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.

M A Gleisner1, M Rosemblatt, J A Fierro, M R Bono.   

Abstract

BACKGROUND: Dendritic cells (DCs) are professional antigen-presenting cells able to induce immunity or tolerance. The interactions of immature DCs with naive T lymphocytes induce peripheral tolerance through mechanisms that include anergy or deletion of lymphocytes or the generation of regulatory T cells. Because of the central role of DCs in the immune response, they are potential targets for the induction of experimental tolerance. Thus, the generation of immature (tolerogenic) DCs able to capture and present alloantigens to T cells represents an important aim in our efforts to achieve better transplant acceptance.
METHODS: In this work, we generated immature DCs by using vitamin D(3) (VD3) during the process of DC differentiation.
RESULTS: The VD3-DCs showed an immature phenotype characterized by a low expression of major histocompatibility complex antigens of class II, CD86, and CD80 molecules and the secretion of a tolerogenic cytokine pattern. Furthermore, we showed that VD3-DCs phagocytose apoptotic allogeneic cells efficiently without inducing DC maturation or activation. Most important, our experiments demonstrated that mice treated with VD3 produce immature DCs in vivo, and that DCs from VD3-treated mice immunized with allogeneic apoptotic cells maintained their tolerogenic phenotype.
CONCLUSION: Our results show that allogeneic apoptotic cells in combination with VD3 generate DCs with tolerogenic characteristics that could be used to induce tolerance towards alloantigens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839264     DOI: 10.1016/j.transproceed.2011.06.007

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  11 in total

1.  Mouse T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex.

Authors:  Daniel Blumenthal; Vidhi Chandra; Lyndsay Avery; Janis K Burkhardt
Journal:  Elife       Date:  2020-07-27       Impact factor: 8.140

2.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

4.  Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response.

Authors:  Xiyue He; Juan Yan; Xiaotong Zhu; Qinghui Wang; Wei Pang; Zanmei Qi; Meilian Wang; Enjie Luo; Daniel M Parker; Margherita T Cantorna; Liwang Cui; Yaming Cao
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

5.  Gal-1 regulates dendritic cells-induced Treg/Th17 balance though NF-κB/RelB-IL-27 pathway.

Authors:  Hao Lu; Xinzheng Dai; Xu Li; Yu Sun; Yangjuan Gao; Chuanyong Zhang
Journal:  Ann Transl Med       Date:  2019-11

Review 6.  Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice.

Authors:  Alex Steimle; Julia-Stefanie Frick
Journal:  J Immunol Res       Date:  2016-02-11       Impact factor: 4.818

Review 7.  Transplant tolerance: new insights and strategies for long-term allograft acceptance.

Authors:  Paulina Ruiz; Paula Maldonado; Yessia Hidalgo; Alejandra Gleisner; Daniela Sauma; Cinthia Silva; Juan Jose Saez; Sarah Nuñez; Mario Rosemblatt; Maria Rosa Bono
Journal:  Clin Dev Immunol       Date:  2013-05-12

Review 8.  Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges.

Authors:  Ammar Ebrahimi; Seyed Ahmad Hosseini; Fakher Rahim
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

Review 9.  Regulatory dendritic cells for immunotherapy in immunologic diseases.

Authors:  John R Gordon; Yanna Ma; Laura Churchman; Sara A Gordon; Wojciech Dawicki
Journal:  Front Immunol       Date:  2014-01-31       Impact factor: 7.561

Review 10.  Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man.

Authors:  Verena K Raker; Matthias P Domogalla; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2015-11-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.